Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient

被引:24
|
作者
Mandala, Mario [1 ]
Merelli, Barbara [1 ]
Indriolo, Amedeo [2 ]
Tondini, Carlo [1 ]
机构
[1] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Med Oncol Unit, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Gastroenterol Unit, Bergamo, Italy
关键词
ANTI-PD-1; THERAPY; IPILIMUMAB;
D O I
10.1016/j.ejca.2018.02.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:130 / 132
页数:3
相关论文
共 50 条
  • [11] Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy
    Shustef, Elina
    Torres-Cabala, Carlos A.
    Curry, Jonathan L.
    Tetzlaff, Michael T.
    Nagarajan, Priyadharsini
    Ivan, Doina
    Prieto, Victor G.
    Aung, Phyu P.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2017, 39 (08) : E116 - E118
  • [12] IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
    Chelsea A. Taylor
    Robert A. Watson
    Orion Tong
    Weiyu Ye
    Isar Nassiri
    James J. Gilchrist
    Alba Verge de los Aires
    Piyush Kumar Sharma
    Surya Koturan
    Rosalin A. Cooper
    Victoria K. Woodcock
    Elsita Jungkurth
    Brian Shine
    Nicholas Coupe
    Miranda J. Payne
    David N. Church
    Vivek Naranbhai
    Stefan Groha
    Paul Emery
    Kulveer Mankia
    Matthew L. Freedman
    Toni K. Choueiri
    Mark R. Middleton
    Alexander Gusev
    Benjamin P. Fairfax
    Nature Medicine, 2022, 28 : 2592 - 2600
  • [13] Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series
    Spain, Lavinia
    Walls, Gerard
    Messiou, Christina
    Turajlic, Samra
    Gore, Martin
    Larkin, James
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (01) : 113 - 117
  • [14] Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series
    Lavinia Spain
    Gerard Walls
    Christina Messiou
    Samra Turajlic
    Martin Gore
    James Larkin
    Cancer Immunology, Immunotherapy, 2017, 66 : 113 - 117
  • [15] IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
    Taylor, Chelsea A.
    Watson, Robert A.
    Tong, Orion
    Ye, Weiyu
    Nassiri, Isar
    Gilchrist, James J.
    de los Aires, Alba Verge
    Sharma, Piyush Kumar
    Koturan, Surya
    Cooper, Rosalin A.
    Woodcock, Victoria K.
    Jungkurth, Elsita
    Shine, Brian
    Coupe, Nicholas
    Payne, Miranda J.
    Church, David N.
    Naranbhai, Vivek
    Groha, Stefan
    Emery, Paul
    Mankia, Kulveer
    Freedman, Matthew L.
    Choueiri, Toni K.
    Middleton, Mark R.
    Gusev, Alexander
    Fairfax, Benjamin P.
    NATURE MEDICINE, 2022, 28 (12) : 2592 - +
  • [16] Adjuvant therapies in the treatment of stage II and III malignant melanoma
    Kavanagh, D
    Hill, ADK
    Djikstra, B
    Kennelly, R
    McDermott, EMW
    O'Higgins, NJ
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2005, 3 (04): : 245 - 256
  • [17] Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
    Trinh, Beckey
    Sanchez, Guacimara Ortega
    Herzig, Petra
    Laubli, Heinz
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [18] Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
    Ferraresi, Virginia
    Vari, Sabrina
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
  • [19] Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient
    Kissoonsingh, P.
    Sutton, B.
    Iqbal, Syed U.
    Pallan, Lalit
    Steven, Neil
    Khoja, L.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2022, 2022
  • [20] Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma
    Allen, Kevin
    Malo, Mackenze
    Jiao, Rubin
    Dadachova, Ekaterina
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S33 - S33